Skip to main content

Intracranial Mass Lesions

  • Chapter
  • First Online:
Neurology
  • 3101 Accesses

Abstract

Intracranial masses may be life-threatening lesions that are refractory to even the most aggressive treatment or benign and require only occasional observation. Metastatic tumors are the most common intracranial tumors in adults, and usually portend a poor prognosis. Glial tumors may be divided into glioblastoma multiforme and other high-grade tumors which progress despite multimodal treatment and low-grade tumors which may be relatively benign. Meningiomas are most often benign tumors that come to clinical attention by causing mass effect or are noticed incidentally on a neuroimaging study ordered for an unrelated reason. Primary central nervous system lymphoma (PCNSL) may occur in both immunocompromised and immunocompetent patients. Important non-neoplastic supratentorial mass lesions include arteriovenous malformations, abscesses, and tumefactive multiple sclerosis. Sellar region tumors may produce headaches, visual field defects, and extraocular movement disorders. The most common lesions in the sellar region are adenomas, craniopharyngiomas, and meningiomas. Cerebellopontine angle lesions such as vestibular schwannomas may come to clinical attention by producing hearing loss or imbalance. Masses that occur with greater frequency in immunocompromised patients, particularly those with HIV include PCNSL and toxoplasmosis. Patients from the tropics and the developing world are at risk for several infections that may produce cerebral masses, most importantly neurocysticercosis and tuberculosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bernstein M, Berger M. Neuro-oncology: the essentials. 2nd ed. New York: Thieme; 2008.

    Google Scholar 

  • Bonneville F, Sarrazin JL, Marsot-Dupuch K, et al. Unusual lesions of the cerebellopontine angle: a segmental approach. Radiographics. 2001;21:419–38.

    Article  CAS  PubMed  Google Scholar 

  • Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453–61.

    Article  PubMed  Google Scholar 

  • Butteriss DJA, Ismail A, Ellison DW, Birchall D. Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol. 2003;76:662–5.

    Article  CAS  PubMed  Google Scholar 

  • Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008;79:1050–5.

    Article  CAS  PubMed  Google Scholar 

  • Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741–4.

    Article  CAS  PubMed  Google Scholar 

  • Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999;28:81–117.

    Article  CAS  PubMed  Google Scholar 

  • Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology. 1992;34:150–4.

    Article  CAS  PubMed  Google Scholar 

  • Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003.

    Article  CAS  PubMed  Google Scholar 

  • Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76:S20–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Levin VA, Bidaut L, Hou P, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79:1487–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mavrakis AN, Halpern EF, Barker FG, Gonzalez RG, Henson JW. Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer. Neurology. 2005;65:908–11.

    Article  CAS  PubMed  Google Scholar 

  • Norden AD, Young GS, Setayesh K, et al. Bevacizumab for recurrent malignant gliomas. Efficacy, toxicity, and patterns of recurrence. Neurology. 2008;70:779–87.

    Article  CAS  PubMed  Google Scholar 

  • Ogilvy CS, Stieg PE, Awad I, et al. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32:1458–71.

    Article  CAS  PubMed  Google Scholar 

  • Serhal D, Weil RJ, Hamrahian AH. Evaluation and management of pituitary incidentalomas. Cleve Clin J Med. 2008;75:793–801.

    Article  PubMed  Google Scholar 

  • Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476–83.

    Article  CAS  PubMed  Google Scholar 

  • Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66.

    Article  CAS  PubMed  Google Scholar 

  • Wasay M, Kheleani BA, Moolani MK, et al. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. J Neuroimaging. 2003;13:240–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Tarulli, A. (2016). Intracranial Mass Lesions. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-29632-6_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29632-6_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29630-2

  • Online ISBN: 978-3-319-29632-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics